Adial Pharmaceuticals, Inc.
ADIL
$0.3721
$0.00010.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.34% | 25.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.96% | 16.83% | |||
| Operating Income | 16.96% | -16.83% | |||
| Income Before Tax | 12.12% | -7.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.12% | -7.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.12% | -7.63% | |||
| EBIT | 16.96% | -16.83% | |||
| EBITDA | 16.96% | -16.83% | |||
| EPS Basic | 45.89% | -5.58% | |||
| Normalized Basic EPS | 45.92% | 68.67% | |||
| EPS Diluted | 45.89% | -5.58% | |||
| Normalized Diluted EPS | 45.92% | 68.67% | |||
| Average Basic Shares Outstanding | 62.43% | 1.94% | |||
| Average Diluted Shares Outstanding | 62.43% | 1.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||